Inventor · disambiguated record
Lea Aurelie Bouche
Also filed as: BOUCHE LEA AURELIE · BOUCHÉ LÉA · BOUCHÉ LÉA AURELIE
2 granted patents·12 pending applications·0 citations·filing 2018–2025
26Inventor score
Top patents by PatentIndex Score
14 records- 0173US2024132471A1Novel compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0271US12421209B2CompoundsHOFFMANN LA ROCHE·Filed 2025·Granted Sep 23, 2025·0 cites·2 claims
- 0370US2025276958A1CompoundsHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 0462US2024279237A1Fused bicyclic heteroaryl compounds useful as nlrp3 inhibitorsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0562US2024150277A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 0661US2024409553A1Heterocyclic nlrp3 inhibitorsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0761US2024308977A1Pyridazine derivatives as inhibitors of nlrp3HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0860US2024287048A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 0959US2024208928A1Novel compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1058US2025353830A1Novel compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1151US2024279207A1Substituted acyl sulfonamides for treating cancerBROAD INST INC·Filed 2021·Application pending·0 cites
- 1248US2022411381A1Pyrimidinedione derivativesBAYER AG·Filed 2020·Application pending·0 cites
- 1343US12357603B2Acyl sulfonamides for treating cancerBAYER AG·Filed 2020·Granted Jul 15, 2025·0 cites·17 claims
- 1437US2020123147A1Thiazole compounds useful as prmt5 inhibitorsBAYER AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lea Aurelie Bouche files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →